Gilead Sciences Inc. (GILD)
BCBA
Closed
Oct 9, 2026
Day's Range
59,875.0052 wk Range
41,540.00Overview - GILD - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
1,387,826.54T
P/E (Trailing)
‪4.84‬
PEG Ratio
‪-0.0075‬
Price / Sales (TTM)
‪2,481.37‬
Price / Book
‪50.92‬
EV / EBITDA
‪62,209.83‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
14.90B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.35‬
50-Day Avg
‪56,332.50‬
200-Day Avg
‪52,000.20‬
Dividends
Payout Ratio
‪10.85%‬
Frequency
Quarterly
Market Cap - GILD - Gilead Sciences Inc.
Peers - GILD - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- GILDBCBAGilead Sciences Inc.75.38TMarket Cap+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,257.20TMarket Cap+29.46%52-week change57.14P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR353.29TMarket Cap+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR159.66TMarket Cap+22.83%52-week change16.85P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR103.32TMarket Cap+22.93%52-week change6.68P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt75.56TMarket Cap+22.40%52-week change8.00P/E (Trailing)‪9.80%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.69.12TMarket Cap+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
Profile Summary - GILD - Gilead Sciences Inc.
About
Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs in infectious diseases, oncology, and inflammatory conditions across the United States, Europe, and other international markets. Its portfolio centers on HIV treatments, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
